If youre on one of these medicationsor thinking about startinguse this information as a starting point for a detailed conversation with your care team
What to Consider When Choosing a GLP-1 Provider Rachel Pessah-Pollack, MD, a diabetes and metabolism endocrinologist in New Hyde Park, New York, recommends finding a provider who is board-certified and has expertise in weight management, endocrinology, and metabolism
Kostara, Athanasios Papathanasiou, Vasilis Tsimihodimos, Eleni T
Phase 2 trials are designed primarily to assess dose-ranging, safety signals, and preliminary efficacy they are not powered to detect rare adverse events or confirm long-term cardiovascular outcomes
Participants received weekly injections over 48 weeks, with doses ranging from 1 mg to 12 mg